Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISEDRONIC ACID for Osteoporosis postmenopausal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where RISEDRONIC ACID was used for Osteoporosis postmenopausal.

Most Reported Side Effects for RISEDRONIC ACID

Side Effect Reports % Deaths Hosp.
Drug ineffective 127 27.6% 7 89
Nausea 106 23.0% 3 70
Off label use 95 20.6% 8 76
Infection 89 19.3% 5 69
Rheumatoid arthritis 89 19.3% 7 67
Diarrhoea 84 18.2% 5 68
Drug hypersensitivity 83 18.0% 8 73
Mobility decreased 82 17.8% 3 74
Pulmonary fibrosis 79 17.1% 3 70
Loss of consciousness 78 16.9% 7 71
Pain 78 16.9% 3 65
Vomiting 78 16.9% 3 65
Condition aggravated 76 16.5% 3 66
Intentional product use issue 75 16.3% 7 69
Nodule 75 16.3% 0 55

Other Indications for RISEDRONIC ACID

Product used for unknown indication (161) Osteoporosis (154) Bone density abnormal (9) Osteoporosis prophylaxis (7) Rheumatoid arthritis (6) Bone disorder (5) Osteopenia (5)

Other Drugs Used for Osteoporosis postmenopausal

DENOSUMAB (18,350) ABALOPARATIDE (7,932) PROLIA (1,775) ROMOSOZUMAB-AQQG (1,401) TERIPARATIDE (263) ALENDRONATE (262) ZOLEDRONIC ACID (225) ALENDRONATE\CHOLECALCIFEROL (135) IBANDRONIC ACID (116) ALENDRONIC ACID (105)

Related Pages

RISEDRONIC ACID Full Profile All Osteoporosis postmenopausal Drugs RISEDRONIC ACID Demographics RISEDRONIC ACID Timeline